The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Outcomes of second allogeneic hematopoietic stem cell transplantation (SCT) for patients with acute lymphoblastic leukemia (ALL).
LM Poon
No relevant relationships to disclose
Roland Bassett
No relevant relationships to disclose
Gabriela Rondon
No relevant relationships to disclose
Laura L Worth
No relevant relationships to disclose
Laurence Cooper
No relevant relationships to disclose
Uday R. Popat
No relevant relationships to disclose
Yago Nieto
No relevant relationships to disclose
Marcos J.G. De Lima
No relevant relationships to disclose
Richard E. Champlin
No relevant relationships to disclose
Partow Kebriaei
No relevant relationships to disclose